Depot-opioids for Pre- and Postoperative Pain Relief After Primary Knee Arthroplasty.Tapentadol vs Oxycodone vs Placebo

Joint Diseases Clinical Trial

Official title:

Depot-opioids for Pre- and Postoperative Pain Relief After Primary Knee Arthroplasty. A Double Blinded Randomized Controlled Study. Tapentadol vs Oxycodone vs Placebo

Clinical Trial Details — Status: Completed

Administrative data

• NCT number: NCT02604446
• Other study ID #: TPO-150
• Secondary ID: 2015-000295-94
• Status: Completed
• Phase: Phase 3
• Start date: September 2015
• Est. completion date: February 2019

Study information

• Verified date: November 2021
• Source: St. Olavs Hospital
• Contact: n/a
• Is FDA regulated: No
• Study type: Interventional

Clinical Trial Summary

This study will provide knowledge about the use of long-acting opioids for pain relief after primary knee arthroplasty. The investigators will compare depot tapentadol, depot oxycodone and placebo for effect on pain relief and side effects. The three study groups reflect the three different postoperative pain regimens that have been used the last years at St. Olavs Hospital, so investigators know that no patient will receive an inadequate pain treatment. The purpose of the study is to find which of the three treatments that gives the best pain relief with the least amount of side effects. The results will be of use for postoperative pain treatment for knee arthroplasty, but also for other types of major surgery. Similar studies that are not sponsored by pharmaceutical industry have not been published yet.

Recruitment information / eligibility

• Status: Completed
• Enrollment: 134
• Est. completion date: February 2019
• Est. primary completion date: February 2019
• Accepts healthy volunteers: No
• Gender: All
• Age group: 18 Years and older

Eligibility

Inclusion Criteria:

• scheduled for knee arthroplasty at St. Olavs University Hospital
• consent in participation in the study

Exclusion Criteria:

• Contraindications for any of the study drugs
• Lactose intolerance
• Known hypersensitivity against any of the additives
• Chronic Obstructive Pulmonary Disease (COPD) grade 3 or 4
• Paralytic ileus
• Known alcohol or medical addiction/abuse
• History of asthma, urticaria or allergic reaction caused by acetyl salicylic acid or other NSAIDs
• Peptic ulcer
• Hemophilia
• Gastrointestinal bleeding
• Cerebrovascular bleeding
• Inflammatory bowel disease (ulcerous colitis, Crohn disease)
• Concomitant use of the following drugs: ACE-inhibitors, AT2-blockers, SSRI, Anti-psychotic drugs, MAO-inhibitors, Atazanavir and Nelfinavir (medicine used for HIV-infection)
• Known kidney failure (creatinin level above reference value)
• Known heart failure (NYHA III-IV)
• Pregnancy
• Women in fertile age with risk of pregnancy
• Nursing women
• operated under general anesthesia without use of spinal anesthesia
• using opioids on a regular basis except users of codeine or tramadol, or known former abuse of opioids
• Cognitive failure or other factors which make follow up impossible (for example language difficulties)
• No cell phone or internet connection at home (making follow up difficult)

Related Conditions & MeSH terms

• Joint Diseases
• Pain, Postoperative

Intervention

Drug:
• Tapentadol

• Oxycodone

• Placebo

• usual pain treatment
premedication of Dexamethasone, Paracetamol, Vimovo; postoperative Paracetamol and Vimovo

Locations

Country	Name	City	State
Norway	Anestesiavdelingen, St Olavs Hospital	Trondheim

Sponsors (1)

Lead Sponsor	Collaborator
St. Olavs Hospital

Country where clinical trial is conducted

Norway, 

References & Publications (1)

Rian T, Skogvoll E, Hofstad J, Høvik L, Winther SB, Husby VS, Klaksvik J, Egeberg T, Sand K, Klepstad P, Wik TS. Tapentadol vs oxycodone for postoperative pain treatment the first 7 days after total knee arthroplasty: a randomized clinical trial. Pain. 20 — View Citation

Outcome

Type	Measure	Description	Time frame	Safety issue
Primary	Area under curve (AUC) based on daily numeric rating score (NRS) scale 1-10 for pain by mobilization the first 8 postoperative days	NRS-scores	8 days
Secondary	Pain at rest in the previous 24 hours	NRS-scores 1-10 scale	8 days
Secondary	worst pain in the previous 24 hours	NRS-scores 1-10 scale	8 days
Secondary	quality of sleep in the previous night	NRS-scores 1-10 scale	8 days
Secondary	nausea in the previous 24 hours	NRS-scores 1-10 scale	8 days
Secondary	obstipation in the previous 24 hours	NRS-scores 1-10 scale	8 days
Secondary	dizziness in the previous 24 hours	NRS-scores 1-10 scale	8 days
Secondary	sedation in the previous 24 hours	NRS-scores 1-10 scale	8 days
Secondary	headache	NRS-scores 1-10 scale	8 days in the previous 24 hours